Medicure (MCUJF) Income from Continuing Operations (2009 - 2026)

Medicure's (MCUJF) quarterly Income from Continuing Operations came in at 296057.51 in Q1 2026, down 168.74% year-on-year from 430694.38 in Q1 2025, and up 95.72% quarter-over-quarter from 6923468.06 in Q4 2025.

Medicure (MCUJF) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Medicure's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 296057.51 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 168.74% year-over-year to 296057.51 in Q1 2026; TTM through Mar 2026 was 8801174.06, a 2368.83% decrease from a year earlier, with the FY2025 full-year figure at 5079474.98, down 569.33% from the prior year.
  • Income from Continuing Operations climbed to 296057.51 in Q1 2026 per MCUJF's latest filing, from 6923468.06 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 3974512.36 in Q4 2022 and bottomed at 6923468.06 in Q4 2025.
  • The 5-year median for Income from Continuing Operations is 83858.79 (2024), against an average of 182943.88.
  • Across the five-year window, Income from Continuing Operations jumped 695.55% in 2024 and slumped 1648.95% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 3974512.36 in 2022, then tumbled by 130.12% to 1197292.91 in 2023, then jumped by 66.94% to 395864.57 in 2024, then slumped by 1648.95% to 6923468.06 in 2025, then jumped by 95.72% to 296057.51 in 2026.
  • Per Business Quant, the three latest MCUJF Income from Continuing Operations figures stand at 296057.51 (Q1 2026), 6923468.06 (Q4 2025), and 1014382.46 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Medicure 8.77 Mn 7.64 Mn 2.57 Mn -296,057.51

Historic Data

Download Data
DateValue
Mar 31, 2026 -296,057.51
Dec 31, 2025 -6.92 Mn
Sep 30, 2025 -1.01 Mn
Jun 30, 2025 -567,266.02
Mar 31, 2025 430,694.38
Dec 31, 2024 -395,864.57
Sep 30, 2024 498,476.32
Jun 30, 2024 -889,798.05
Mar 31, 2024 83,858.79
Dec 31, 2023 -1.20 Mn
Sep 30, 2023 62,658.16
Jun 30, 2023 188,346.47
Mar 31, 2023 201,197.41
Dec 31, 2022 3.97 Mn
Sep 30, 2022 1.89 Mn
Jun 30, 2022 568,646.97
Mar 31, 2022 280,263.77
Sep 30, 2021 -2.04 Mn
Jun 30, 2021 407,577.11
Mar 31, 2021 828,023.88